Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium
on behalf of the Psychiatric Genomics Consortium Substance Use Disorders Workgroup
Dive into the research topics of 'Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium'. Together they form a unique fingerprint.